DZ Bank’s Allena Pharmaceuticals ALNA Stock Holding History

DZ Bank’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-300	Closed	-$3K	–	1139
2018 Q1	$3K	Buy	+300	New	+$2.51K	﹤0.01%	1128

Other funds holding ALNA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DZ Bank's ALNA Position: Q2 2018 in Review

DZ Bank sold out of Allena Pharmaceuticals (ALNA) in Q2 2018, closing a stake of 300 shares — an estimated $3K sold.

DZ Bank first reported a position in ALNA in Q1 2018 and held it in 1 quarter. The position peaked at $3K in Q1 2018. 49 funds tracked by Wall St. Rank hold ALNA as of Q2 2018.

DZ Bank reported no remaining Allena Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 300 Allena Pharmaceuticals shares in Q2 2018, an estimated $3K.
DZ Bank first reported a position in Allena Pharmaceuticals in Q1 2018 and held it in 1 quarter.
DZ Bank's Allena Pharmaceuticals position peaked at $3K in Q1 2018.
49 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.